Key Takeaways
- Oklo shares plummeted 9.1% during trading to approximately $45.68, with volume exceeding 10.6 million shares
- Fourth-quarter earnings showed a loss of ($0.27) per share, significantly worse than analyst expectations of ($0.17)
- Company executives and insiders dumped more than 1.2 million shares valued at approximately $100.7 million during the past quarter
- On March 30 alone, two board members liquidated a combined 14,500 shares
- Major Wall Street firms including UBS, Goldman Sachs, and B. Riley lowered their price targets, pointing to capital intensity and operational challenges
Oklo’s recent performance tells a troubling story. After reaching heights above $190 within the past year, shares have crashed 30% since the start of 2025 and now trade substantially below both the 50-day moving average of $68.12 and the 200-day moving average of $94.27.
The recent downturn was triggered by a perfect storm of negative developments — disappointing financial results, reduced analyst forecasts, and a wave of insider stock sales that’s raising red flags among investors.
Regarding quarterly performance, Oklo revealed a per-share loss of $0.27, falling short of Wall Street’s ($0.17) expectation by ten cents. While the absolute variance may seem modest, it carries weight for a pre-commercial enterprise where meeting milestones is critical to maintaining investor confidence.
Wall Street analysts compounded the pessimism. Major firms including UBS, Goldman Sachs, and B. Riley all reduced their price objectives, highlighting substantial capital demands, accelerating cash consumption, and potential delays in bringing Oklo’s innovative reactor designs to market. These are legitimate worries — the company continues to operate without revenue generation, maintains significant spending levels, and hasn’t yet obtained complete design certification from the Nuclear Regulatory Commission.
That said, optimism hasn’t completely evaporated. Cantor Fitzgerald maintained its “overweight” stance with a $122 target as of March 18. The overall Street consensus sits at “Moderate Buy” with an average target of $84.30 — representing nearly 100% upside from current levels. Texas Capital even bumped Oklo to “Strong Buy” back in January.
Massive Insider Sales Raise Eyebrows
The wave of insider transactions has emerged as one of the most concerning signals lately. Throughout the previous quarter, company insiders offloaded 1,222,424 shares totaling roughly $100.7 million in value.
Chief Executive Jacob DeWitte disposed of 231,657 shares in January at $99.25 per share — trimming his personal holdings by 21.88%. Chief Financial Officer Richard Craig Bealmear followed suit in March, selling 72,090 shares at $60.00, which represented a 15.74% reduction in his position.
On March 30, coinciding with the sharp stock decline, two board members also participated in selling. Richard Kinzley liquidated 4,000 shares for $208,360, while John M. Jansen sold 10,500 shares generating $540,960 in proceeds.
When insider selling reaches this magnitude, particularly from senior leadership, it naturally prompts investor concern — regardless of whether executives characterize the transactions as pre-planned.
Positive Factors Still in Play
Despite mounting pressures, Oklo retains several promising elements.
The company maintains more than $2.6 billion in available liquidity, providing substantial financial cushion. Critical approvals from the Department of Energy are secured, and the Meta-backed Ohio development project continues progressing. The company has also recently broadened its fast-reactor collaboration with Swedish company Blykalla.
Its Atomic Alchemy division is advancing a radioisotope pilot facility with Department of Energy support, creating an additional potential revenue stream in the future.
With a market capitalization of $7.93 billion and zero current revenue, the valuation anticipates a future that still involves considerable execution uncertainty. The technical indicators — negative MACD readings, trading beneath critical moving averages — capture this ongoing tension.
Monday’s closing price stood at $45.68, representing a 9.1% single-session decline.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
